期刊文献+

耐利福平结核分枝杆菌rpoB基因序列研究 被引量:2

Study on rpoB genes of rifampin-resistant Mycobacterium tuberculosis
下载PDF
导出
摘要 目的研究杭州地区结核分枝杆菌(Mycobacteriumtuberculosis)对利福平(RFP)的耐受与rpoB基因突变的关系。方法随机挑选了90例结核杆菌感染的病例,选择了利福平作为主要的药物进行药敏实验,PCR扩增39株耐RFP结核分支杆菌的rpoB基因片段(580bp);测定扩增片段的序列,并与美国国立生物信息中心(www.ncbi.nlm.nih.gov/nucleotide)检索获得结核杆菌野生株(利福平敏感株)序列(登陆号:AJ749948)作对比分析。结果结果显示PCR结核测序方法得到了39例结核杆菌耐药株,51例敏感株,与药敏实验的方法检测的结果完全一致。测定的11株临床分离的耐药株中,526位或531位有突变,其中526位有突变的有7株,占耐药测定株63.6%,531位突变的有4株,占耐药测定株36.4%,未见两位点同时突变。检测的11株敏感株,未见526位或531位有突变。结论杭州地区结核分支杆菌耐利福平的发生与rpoB基因的526位或531位突变密切相关,与国外的报告基本相似。但526位突变占耐药测定株高达63.6%,如此高比例目前国内外未见相似报道。PCR扩增和产物测序将是临床检测结核分支杆菌耐利福平和耐多药的一种迅速、准确的方法。 Objective To investigate the mutations of rpoB genes interrelated rifampin (RFP) resistance of Mycobacterium tuberculosis(Mt) in Hangzhou area. Methods 90 strains of Mt from the patients were chosen randomly, rpoB genes were performed by PCR amplification and direct sequencing, and contrasted the rpoB DNA sequences of the strains with the rpoB sequences of Mt wild-type strain (RFP sensitive). Results The results indicated that there were 39 strains of RFP-resistant Mt and 51 strains of RFP-sensitive Mt. Furthermore, the results from PCR and sequencing were the same to the results from drug susceptibility testing. The rate of RFP-resistant Mt was 43%. The substitution at single codon in 526(63.6%) or 531(36.4 %) was found in all 11 strains of RFP-resistant. 11 sensitive strains of RFP were not detected the mutation in 531 or 526 points. Conclusions The results reveal that there is a strong correlation between resistance to rifampin and rpoB mutations of M. tuberculosis, but the report about the substitution at single codon mutation in 526 (63.6%) have not found in published reports, the sequencing analysis of the rpoB fragment amplified by PCR may accurately identify the rifampin-resistant or multiple resistant strains of M. tuberculosis.
出处 《江西医学检验》 2006年第3期200-202,287,共4页 Jiangxi Journal of Medical Laboratory Sciences
基金 浙江省医药卫生科学研究基金2003J005
关键词 结核分支杆菌 RPOB基因 利福平 耐药 Mycobacterium tuberculosis RpoB genes Rifampin Drug resistance
  • 相关文献

参考文献11

  • 1Iseman MD. Treatment of muhidrug resistant tuberculosis[J]. N Engl J Med, 1993,329(??/):784.
  • 2Telenti A, Imboden P, Marchesi F, el al. Detection of rifampiein-resislance mutations in Myeobaeterium tuberculosis[J]. Lancet,1993,341 (8): 647.
  • 3Karahan ZC, Akar N. Restriction endonuclease analysis as a solution for determining rifampin resistance mutations by automated DNA sequencing in heteroresistant Myeobacterium tuberculosis strains[J]. Microb Drug Resist.2005,11(2):137 - 140.
  • 4Haake DA, Champion CI, Martinich C, et al. Molecular cloning and sequence analysis of the gene encoding OmpLl ,a transmembrane outer membrane protein of pathogenic leptospira spp[J]. J Bacteriol,1993,175 (13):4225.
  • 5晏菊芳,鲍朗,伍卫华,万波,李胜富.中国钩端螺旋体强毒株017膜蛋白基因的质粒载体构建及表达[J].中华微生物学和免疫学杂志,1999,19(2):117-120. 被引量:5
  • 6乐军,曾而良,谢建平,李瑶,梁莉,王洪海.中国耐多药结核分枝杆菌临床分离株rpoB基因突变特点[J].Acta Genetica Sinica,2004,31(12):1332-1336. 被引量:23
  • 7Ramaswamy SV, Amin AG, Goksel S, et at. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis [J]. Antimicrob Agents Chemother,2000,44(2):326 - 336.
  • 8Qian L, Abe C, Lin TP, et .al. rpoB genotypes of Mycobaceri umt uberculosi.s Beijing family isolates from East Asian countries[J]. J Clin Microbiol, 2002,40(3): 1091.
  • 9Yamada T, N agata A, Ono Y, et al. A heration of ribosomes and RNA polymerase in durg- rdsestant clinical isolates of M. tuberculsis [J]. Antimicrob Zgent Cheother. 1985, 27(11):921.
  • 10Miller LP, Crawford JT, Shinnick TM, et al. The rpoB gene of myrobacterium tuberculosis[J]. Antimicrob Agents Cheother, 1994,38(4): 805 - 811.

二级参考文献24

  • 1陈在,戴保民,张义正,李胜富.我国主要致病钩端螺旋体DNA与OmpL1基因同源性的研究[J].华西医科大学学报,1995,26(3):248-251. 被引量:7
  • 2王斌,邵一鸣,曾毅.HIV-1SF2株env基因(120)在大肠杆菌中的表达[J].病毒学报,1996,12(1):18-22. 被引量:6
  • 3张智清,姚立红,侯云德.含P_RP_L启动子的原核高效表达载体的组建及其应用[J].病毒学报,1990,6(2):111-116. 被引量:178
  • 4Espinal M A,Laszlo A,Simonsen L,Boulahbal F,Kim S J,Reniero A,Hoffner S,Rieder H L,Binkin N,Dye C,Williams R,Raviglione M C.Global trends in resistance to antituberculosis drugs.N Engl J Med,2001,344(17):1294~1303.
  • 5Dye C,Williams B G,Espinal M A,Raviglione M C.Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.Science,2002,295(5562):2042~2046.
  • 6Becerra M C,Bayona J,Freeman J,Farmer P E,Kim J Y.Redefining MDR-TB transmission-drug resistance'hot spots'.Int J Tuberc Lung Dis,2000,4(5): 387~394.
  • 7Dye C,Scheele S,Dolin P,Pathania V,Raviglione M C.Consensus statement.Global burden of tuberculosis: estimated incidence,prevalence,and mortality by country.WHO Global Surveillance and Monitoring Project.JAMA,1999,18:677~686.
  • 8Dye C,Williams B G.Criteria for the control of drug-resistant tuberculosis.Proc Natl Acad Sci USA,2000,97(14):8180~8185.
  • 9Drobniewski F A,Wilson S M.The rapid diagnosis of isoniazid and rifampin resistance in Mycobacterium tuberculosis--a molecular story.J Med Microbiol,1998,47(3): 189~196.
  • 10Ramaswamy S,Musser J M.Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis:1998 update.Tuberc Lung Dis,1998,79:3~29.

共引文献26

同被引文献12

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部